权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Na,K-ATPase as an Integrator of the Calcium-signaling Machinery

Na,K-ATP 酶作为钙信号传导机制的整合者

基本信息

批准号：
7539561
负责人：
Zijian Xie
金额：
$ 4.25万
依托单位：
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-07-01 至 2011-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7539561
关键词：
1,2-diacylglycerol 1-Phosphatidylinositol 3-Kinase ATP phosphohydrolase Abbreviations Affect Binding Biochemical Biological Assay Blood Pressure Blood Vessels Calcium Calcium Signaling Cardiac Glycosides Cardiovascular Diseases Cardiovascular Physiology Caveolae Cell membrane Cell physiology Complex Cyan Fluorescent Protein Cyclodextrins Cyclophosphamide/Fluorouracil/Prednisone Diglycerides Dimethyl Suberimidate Disruption Dithiothreitol Dominant-Negative Mutation Dose Endocytosis Enzymes Epidermal Growth Factor Receptor Epithelial Cells Family Fluorescence Resonance Energy Transfer Functional disorder Genetic Green Fluorescent Proteins Heart Diseases Hypertension ITPR1 gene Image Image Analysis In Vitro Inositol Ion Channel Ion Pumps Kidney Knock-in Mouse LLC-PK1 Cells Laboratories Lead Modeling Molecular Na(+)-K(+)-Exchanging ATPase Ouabain PH Domain Pharmaceutical Preparations Phosphatidylinositol 4,5-Diphosphate Phosphatidylinositols Phospholipase C Phosphotransferases Physiology Plants Play Propionates Protein Kinase Protein Kinase C Protein Tyrosine Kinase Proteins Purpose RNA Interference Reactive Oxygen Species Receptor Protein-Tyrosine Kinases Recruitment Activity Regulation Renal function Reporter Research Research Personnel Role Sarcoplasmic Reticulum Second Messenger Systems Signal Transduction Small Interfering RNA Sodium Chloride System Testing Therapeutic Work base blood pressure regulation crosslink extracellular kidney cell knock-down novel strategies pressure prevent programs protein protein interaction receptor receptor function receptors for activated C kinase red fluorescent protein response second messenger time use trafficking tripolyphosphate

项目摘要

Na/K-ATPase belongs to the family of P-type ATPases and was discovered as an energy transducing ion pump. A major difference between the Na/K-ATPase and other P-type ATPases is its ability to bind cardiotonic steroids (CIS) such as ouabain. While endogenous CTS regulate blood pressure via their effects on vasculature and renal salt handling, the plant-derived CTS have been used as drugs for more than 200 years. Recently, we have demonstrated that the Na/K-ATPase is an important receptor that resides in caveolae and interacts directly with Src, a non-receptor tyrosine kinase. We know now that the effects of low doses of ouabain on many cellular functions are not due to the simple inhibition of the ATPase; rather they require the activation of the Na/K-ATPase/Src receptor complex. In addition, the Na/K-ATPase contains multiple binding motifs (domains) and is capable of bringing Src and other signaling enzymes to their effectors such as ion channels. These findings have led the research field to look at the Na/K-ATPase not only as an ion pump, but also a classical receptor complex. This shift of the paradigm has brought about an important question: which regulatory purposes does this signaling Na/K-ATPase serve in regulation of cellular functions that are relevant to the physiology of endogenous CTS (e.g.blood pressure control)? This application is proposed to bridge this gap by studying the most likely target of this receptor complex, namely the Ca2+-signaling module because changes in intracellular Ca2+ are known to play a key role in regulation of vascular function and renal salt handling. Specifically, we will investigate how the Na/K-ATPase integrates multiple constituents into a functional Ca2+-signaling module in renal epithelial cells. We propose to use a combined biochemical, cellular, genetic and dynamic imaging approach to 1) define the molecular mechanism by which the Na/K-ATPase integrates Src/PLC-y/PKC and IPS receptor into a dynamic Ca2+ signaling module; 2) reveal whether disruption of the interaction between the Na/K-ATPase and IPS receptors affects IPS receptor trafficking and ouabain-induced Ca2+ signaling; And 3) identify the plasma membrane channel (s) that interacts with the Na/K-ATPase and is responsible for ouabain-induced Ca2+ influx. These studies will not only relate the newly discovered receptor function of the Na/K-ATPase to renal physiology of CTS,but also provide detailed mechanistic information on the formation of a Ca2+-signaling module that will eventually give us a new target for developing therapeutic approaches to renal and cardiovascular diseases involving dysfunction of intracellular Ca regulation. Calcium is a universal second messenger that plays an essential role in control of kidney and cardiovascular function. Abnormality in intracellular calcium regulation will lead to both kidney and heart diseases such as hypertension. We are using a simple model to dissect the formation of a very important calcium controlling system in kidney cells and to investigate how we can manipulate this system to eventually develop new approaches to prevent renal and cardiovascular diseases.

Na/K-ATPase属于P型ATPase家族，是一种能量转导离子打气筒。Na/K-ATPase与其他P型ATPase的主要区别在于其结合能力强心类固醇(CIS)，如哇巴因。而内源性CTS通过其受体调节血压对血管系统和肾盐处理的影响，植物来源的CTS已被用作药物超过 200年了。最近，我们已经证明，Na/K-ATPase是一种重要的受体，存在于并直接与非受体酪氨酸激酶Src相互作用。我们现在知道，低收入的影响哇巴因对许多细胞功能的影响并不是由于对ATPase的简单抑制；相反，它们需要激活Na/K-ATPase/Src受体复合体。此外，Na/K-ATPase还包含多个结合基序(结构域)，并能够将Src和其他信号酶带到他们的效应器，如离子通道。这些发现导致研究领域关注Na/K-ATPase 不仅可以作为离子泵，也可以作为经典的受体复合体。这种范式的转变带来了一种重要的问题：这个信号转导的Na/K-ATPase在调节与内源性CTS的生理相关的细胞功能(例如，血压控制)？这通过研究这种受体复合体最可能的靶点，即钙信号模块，因为细胞内钙离子的变化被认为在调节血管功能和肾盐处理。具体地说，我们将研究Na/K-ATPase如何整合在肾上皮细胞中，多种成分组成了一个功能性的钙信号模块。我们建议使用结合生化、细胞、遗传和动态成像方法来1)定义分子 Na/K-ATPase结合Src/PLC-y/PKC和IPS受体形成动态钙的机制信号模块；2)揭示Na/K-ATPase与IPS之间的相互作用是否被破坏受体影响IPS受体转运和哇巴因诱导的钙信号转导；3)识别血浆与Na/K-ATPase相互作用并负责哇巴因诱导钙离子的膜通道(S) 涌入。这些研究不仅将新发现的Na/K-ATPase的受体功能与肾脏联系起来 CTS的生理学，但也提供了有关形成钙信号的详细机制信息模块，最终将给我们一个新的目标，开发治疗肾脏和涉及细胞内钙调节功能障碍的心血管疾病。钙是一种普遍存在的第二信使，在控制肾脏和心血管方面起着至关重要的作用功能。细胞内钙调节异常会导致肾脏和心脏疾病，如高血压。我们正在使用一个简单的模型来剖析一种非常重要的钙控制的形成系统在肾脏细胞中，并研究我们如何操纵这个系统，最终开发出新的预防肾脏和心血管疾病的方法。